Evidence map›Paper›PMID 27821281›Full record

ArticleInternational journal for parasitology. Drugs and drug resistance2016

Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V.

Mary C Oguike, Catherine O Falade, Elvis Shu, Izehiuwa G Enato, Ismaila Watila, Ebenezer S Baba, Jane Bruce, Jayne Webster, Prudence Hamade, Sylvia Meek and 4 more

3 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in International journal for parasitology. Drugs and drug resistance, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04634695 unknown statusnot on this mapstarted 2020, after this paper: background citation

Assessing the Prevalence and Impact of Dihydropteroate Synthase-431V Mutation on the Protective Efficacy of Intermittent Preventive Treatment During Pregnancy Using Sulphadoxine-pyrimethamine

Typeobservational_patient_registrySponsorObafemi Awolowo UniversityRan2020 to 2021Enrolled288ConditionsPregnancy Malaria
NCT06166498 phase3completednot on this mapstarted 2024, after this paper: background citation

Effect of Single-course Malaria Chemoprevention on Clearance of and Protection From Plasmodium Falciparum Infection in the Presence of Resistance-associated Genotypes in Zambia

TypeinterventionalSponsorLondon School of Hygiene and Tropical MedicineRan2024 to 2025Enrolled600ConditionsMalariaArmsSP (Macleods Pharmaceuticals Ltd), AS (Guilin Pharmaceuticals)
NCT06173206 phase3completednot on this mapstarted 2024, after this paper: background citation

Effect of Single-course Malaria Chemoprevention on Clearance of and Protection From Plasmodium Falciparum Infection in the Presence of Resistance-associated Genotypes in Cameroon

TypeinterventionalSponsorLondon School of Hygiene and Tropical MedicineRan2024 to 2025Enrolled902ConditionsMalariaArmsSP (Macleods Pharmaceuticals Ltd), SPAQ (Guilin Pharmaceuticals), AS (Guilin Pharmaceuticals)
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Deciphering the Impact of Mutations onMolecules (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Application of a new highly multiplexed amplicon sequencing tool to evaluatemedRxiv : the preprint server for health sciences · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Putative molecular markers ofFrontiers in epidemiology · 2024
    Article
  16. Article
  17. Article
  18. Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Mary C OguikeDepartment of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: mary.oguike@lshtm.ac.uk.
Catherine O FaladeDepartment of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Elvis ShuDepartment of Pharmacology and Therapeutics, College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria.
Izehiuwa G EnatoDepartment of Child Health, University of Benin Teaching Hospital, Benin City, Nigeria.
Ismaila WatilaDepartment of Paediatrics, Specialist Hospital Maiduguri, Borno State, Nigeria.
Ebenezer S BabaMalaria Consortium, Regional Office for Africa, Kampala, Uganda.
Jane BruceDepartment of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Jayne WebsterDepartment of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Prudence HamadeMalaria Consortium, London, United Kingdom.
Sylvia MeekMalaria Consortium, London, United Kingdom.
Daniel ChandramohanDepartment of Disease Control, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Colin J SutherlandDepartment of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
David WarhurstDepartment of Pathogen Molecular Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Cally RoperDepartment of Pathogen Molecular Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
London School of Hygiene & Tropical Medicine · GBMalaria Consortium · GBMalaria Consortium · UGUniversity of Benin Teaching Hospital · NGUniversity of Ibadan · NGUniversity of Maiduguri · NGUniversity of Nigeria · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are few published reports of mutations in dihydropteroate synthetase (dhps) and dihydrofolate reductase (dhfr) genes in P. falciparum populations in Nigeria, but one previous study has recorded a novel dhps mutation at codon 431 among infections imported to the United Kingdom from Nigeria. To assess how widespread this mutation is among parasites in different parts of the country and consequently fill the gap in sulfadoxine-pyrimethamine (SP) resistance data in Nigeria, we retrospectively analysed 1000 filter paper blood spots collected in surveys of pregnant women and children with uncomplicated falciparum malaria between 2003 and 2015 from four sites in the south and north. Genomic DNA was extracted from filter paper blood spots and placental impressions. Point mutations at codons 16, 50, 51, 59, 108, 140 and 164 of the dhfr gene and codons 431, 436, 437, 540, 581 and 613 of the dhps gene were evaluated by nested PCR amplification followed by direct sequencing. The distribution of the dhps-431V mutation was widespread throughout Nigeria with the highest prevalence in Enugu (46%). In Ibadan where we had sequential sampling, its prevalence increased from 0% to 6.5% between 2003 and 2008. Although there were various combinations of dhps mutations with 431V, the combination 431V + 436A + 437G+581G+613S was the most common. All these observations support the view that dhps-431V is on the increase. In addition, P. falciparum DHPS crystal structure modelling shows that the change from Isoleucine to Valine (dhps-431V) could alter the effects of both S436A/F and A437G, which closely follow the 2nd β-strand. Consequently, it is now a research priority to assess the implications of dhps-VAGKGS mutant haplotype on continuing use of SP in seasonal malaria chemoprevention (SMC) and intermittent preventive treatment in pregnancy (IPTp). Our data also provides surveillance data for SP resistance markers in Nigeria between 2003 and 2015.

Indexed as

Drug ResistanceAdultAntimalarialsChildDihydropteroate SynthaseDNA, ProtozoanDrug CombinationsFemaleGene FrequencyHumansMalaria, FalciparumMutant ProteinsMutation, MissenseNigeriaPlasmodium falciparumPolymerase Chain ReactionAntimalarialsDihydropteroate SynthaseDNA, ProtozoanDrug Combinationsfanasil, pyrimethamine drug combinationMutant ProteinsPyrimethamineSulfadoxinedhfrdhpsmutationsNigeriaSulfadoxine-pyrimethamine

Identifiers

PMID27821281
PMCPMC5094156
OpenAlexW2527516004

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.